Search / Trial NCT06232603

Medication Adherence Intervention in Chronic Recurrent Multifocal Osteomyelitis (CRMO)

Launched by SEATTLE CHILDREN'S HOSPITAL · Jan 28, 2024

Trial Information

Current as of December 30, 2024

Terminated

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosis of CRMO
  • Receives clinical care at Seattle Children's Hospital
  • On one or more scheduled prescription medications
  • Exclusion Criteria:
  • -

About Seattle Children's Hospital

Seattle Children's Hospital is a leading pediatric healthcare institution dedicated to advancing the health and well-being of children through innovative clinical research and trials. As a prominent sponsor of clinical studies, the hospital focuses on developing new treatments and therapies that address the unique medical needs of children. With a commitment to excellence, Seattle Children's Hospital collaborates with a network of researchers, healthcare professionals, and academic institutions to ensure rigorous scientific standards and ethical practices in all its clinical investigations. By prioritizing patient safety and scientific integrity, the hospital aims to contribute to the global body of knowledge in pediatric medicine and improve outcomes for children with various health conditions.

Locations

Seattle, Washington, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0